[go: up one dir, main page]

CS94391A2 - Carbapenemic compounds and method of their production - Google Patents

Carbapenemic compounds and method of their production Download PDF

Info

Publication number
CS94391A2
CS94391A2 CS91943A CS94391A CS94391A2 CS 94391 A2 CS94391 A2 CS 94391A2 CS 91943 A CS91943 A CS 91943A CS 94391 A CS94391 A CS 94391A CS 94391 A2 CS94391 A2 CS 94391A2
Authority
CS
Czechoslovakia
Prior art keywords
group
hydrogen
methyl
oxo
formula
Prior art date
Application number
CS91943A
Other languages
Czech (cs)
English (en)
Inventor
Scott Louis Dax
Dennis Dalton Keith
Pamela Loreen Rossman
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CS94391A2 publication Critical patent/CS94391A2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/26—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 4
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CS91943A 1990-04-09 1991-04-05 Carbapenemic compounds and method of their production CS94391A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50613590A 1990-04-09 1990-04-09

Publications (1)

Publication Number Publication Date
CS94391A2 true CS94391A2 (en) 1991-11-12

Family

ID=24013339

Family Applications (1)

Application Number Title Priority Date Filing Date
CS91943A CS94391A2 (en) 1990-04-09 1991-04-05 Carbapenemic compounds and method of their production

Country Status (17)

Country Link
EP (1) EP0451764A1 (fi)
JP (1) JPH04234884A (fi)
AU (1) AU7420591A (fi)
BR (1) BR9101418A (fi)
CA (1) CA2039987A1 (fi)
CS (1) CS94391A2 (fi)
FI (1) FI911666A (fi)
HU (1) HUT57769A (fi)
IE (1) IE911161A1 (fi)
IL (1) IL97797A0 (fi)
MC (1) MC2262A1 (fi)
MX (1) MX25231A (fi)
NO (1) NO911357L (fi)
PT (1) PT97287A (fi)
TW (1) TW216420B (fi)
YU (1) YU62991A (fi)
ZA (1) ZA912279B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
ES2147721T3 (es) * 1990-04-18 2000-10-01 Procter & Gamble Pharma Quinolonil lactamas antimicrobianas.
HUT67423A (en) * 1991-10-01 1995-04-28 Procter & Gamble Pharma Process for the production of antimicrobal compounds containing quinolone moiety and beta-lactam moiety
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
DE4234330A1 (de) * 1992-10-12 1994-04-14 Bayer Ag Chinoloncarbonsäuren
KR100242355B1 (ko) * 1994-08-02 2000-03-02 데이비드 엠 모이어 항미생물 화합물의 제조 방법
AU3154095A (en) * 1994-08-02 1996-03-04 Procter & Gamble Company, The Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
EP0695753A1 (en) * 1994-08-05 1996-02-07 Zeneca Limited Carbapenem derivatives containing a bicyclic substituent, process for their preparation, and their use
US5973142A (en) * 1997-01-21 1999-10-26 Yasuda; Nobuyoshi Process for synthesizing carbapenem intermediates
JP2001519773A (ja) * 1997-01-21 2001-10-23 メルク エンド カンパニー インコーポレーテッド カルバペネム中間体の合成プロセス
US6080854A (en) * 1997-08-25 2000-06-27 Merck & Co., Inc. Process for synthesizing carbapenem intermediates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1179675A (en) * 1981-01-30 1984-12-18 Erwin Gotschi 7-oxo-1-azabicyclo ¬3,2,0| heptene-2-derivatives
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
US4767762A (en) * 1985-12-23 1988-08-30 Abbott Laboratories Tricyclic quinoline and naphthyride antibacterials
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
EP0366193A3 (en) * 1988-10-24 1992-01-08 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial quinolonyl lactams
ES2148135T3 (es) * 1988-10-24 2000-10-16 Norwich Eaton Pharma Nuevos esteres antimicrobianos de quinolonil lactamas.

Also Published As

Publication number Publication date
HUT57769A (en) 1991-12-30
ZA912279B (en) 1992-02-26
JPH04234884A (ja) 1992-08-24
NO911357L (no) 1991-10-10
EP0451764A1 (en) 1991-10-16
MX25231A (es) 1993-10-01
HU911132D0 (en) 1991-10-28
CA2039987A1 (en) 1991-10-10
TW216420B (fi) 1993-11-21
FI911666A (fi) 1991-10-10
AU7420591A (en) 1991-10-10
NO911357D0 (no) 1991-04-08
BR9101418A (pt) 1991-11-26
PT97287A (pt) 1992-01-31
YU62991A (sh) 1994-04-05
IE911161A1 (en) 1991-10-09
MC2262A1 (fr) 1993-04-26
IL97797A0 (en) 1992-06-21
FI911666A0 (fi) 1991-04-08

Similar Documents

Publication Publication Date Title
CS94391A2 (en) Carbapenemic compounds and method of their production
US5093328A (en) Beta-lactam compounds
KR100239612B1 (ko) 항미생물성 락탐-퀴놀론을 함유하는 조성물
KR100244992B1 (ko) 퀴놀론 5-(n-헤테로치환된 아미노) 항미생물제
KR870001693B1 (ko) 1,4-디하이드로-4-옥소나프티리딘 유도체의 제조방법
EP0775702B1 (en) Novel quinolone- or naphthyridonecarboxylic acid derivative or salt thereof
EP0132845A2 (en) Novel 1,8-Naphthyridine derivatives, and process for preparation thereof
HUT66376A (en) Quinolone-carboxylic acids
FI88392B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva acylcefalosporinderivat
KR970704694A (ko) 항미생물 화합물의 제조방법(process for making antimicrobial compounds)
SK37594A3 (en) Method of preparation of antimicrobial quinolonyl lactams
NZ231110A (en) Substituted lactam-quinolones with an ester linkage; analogues, pharmaceutical compositions and methods of treatment
JP4417007B2 (ja) キノロン類及びナフチリジン類の製造方法における環化工程
US5162523A (en) Cephalosporin antibacterial compounds
FI89490C (fi) Foerfarande foer framstaellning av 2-metoximetyl-penemderivat
KR100324621B1 (ko) 퀴놀론이 치환된 옥사졸리디논 유도체 및 그의 제조 방법과 항균제로서의 용도
CZ272099A3 (cs) Karbapenémové sloučeniny, jejich použití a jejich meziprodukty
KR100292395B1 (ko) 페넴화합물
JPS59196895A (ja) ６−（ヒドロキシアルキル）−２−（ヘテロアリ−ルアルキルチオ）ペネム類、それらの製造方法およびそれらを含む医薬組成物
WO1994014819A1 (en) Quinolinecarboxylic acid derivative and process for producing the same
JPH0559052A (ja) 新規三環性化合物又はその塩及びこれを含有する抗菌剤
US5159077A (en) Penam antibacterial compounds
CN1358183A (zh) 喹啉羧酸衍生物或其盐
JP2758413B2 (ja) カルバペネム化合物
JPH0413355B2 (fi)